PMID- 32845361 OWN - NLM STAT- MEDLINE DCOM- 20211119 LR - 20211119 IS - 1861-0692 (Electronic) IS - 1861-0684 (Linking) VI - 110 IP - 5 DP - 2021 May TI - Mid-term hemodynamic and functional results after transcatheter mitral valve leaflet repair with the new PASCAL device. PG - 628-639 LID - 10.1007/s00392-020-01733-7 [doi] AB - AIMS: To examine the functional and hemodynamic mid-term outcome at 5 months of mitral regurgitation (MR) reduction using the PASCAL repair system. METHODS AND RESULTS: Between July 2019 and February 2020 31 consecutive patients with MR 3 +/4 + (mean age 77.5 years, all in New York Heart Association (NYHA) class III-IV, STS score 9.1 +/- 7.4) underwent MR reduction in our institute using the PASCAL device. 61.3% had a functional, 29.0% a degenerative, and 9.7% a mixed etiology. Successful implantation was achieved in 30/31 (96.8%) patients. 27/31 patients (87.1%) completed 5-month follow-up with clinical, echocardiographic, laboratory and hemodynamic assessment. At 5 months, 70.4% of the patients had MR grade